NIH to test experimental drug to curb opioid cravings
A clinical trial of an experimental drug designed to treat cravings associated with opioid use disorder has begun in the NIH Clinical Center. The Phase I trial in healthy adults will assess safety of the experimental compound, ANS-6637, and how it is processed in the body. March 21, 2019